Clinical Trial Update: Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

View source ↗

Summary

A clinical trial update from Fudan University describes evaluating Tpex T-cell subsets in negative tumor-draining lymph nodes to predict how well PD-1 inhibitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Esophageal Cancer | Status: NOT_YET_RECRUITING